KatharineBattMDMSc(She/Her)
Hematology • Raleigh, NCClotting Disorder, Hemophilia & Bleeding Disorder
Scientific Advisor
Dr. Batt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Sprouts Healthcare Consulting
Raleigh, NC 27612
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2010 - 2013- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Hospice and Palliative Medicine, 2009 - 2010
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2006
Certifications & Licensure
NC State Medical License 2013 - 2025
NY State Medical License 2006 - 2013- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Hospice and Palliative Medicine
- National Board of Physicians and Surgeons Internal Medicine
Publications & Presentations
PubMed
- 1 citationsA Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors.Sreenivas P Veeranki, Priti P. Pednekar, Marlon Graf, Rifat Tuly, Michael Recht
Journal of Blood Medicine. 2021-10-21 - 6 citationsHuman papillomavirus-related small cell carcinoma of the oropharynx: a case report and literature reviewMarcelo Bonomi, Tamjeed Ahmed, David S. Warner, Joshua D. Waltonen, Christopher A. Sullivan
Cancers of the Head & Neck. 2017-02-06 - 10 citationsThe option value of innovative treatments for non-small cell lung cancer and renal cell carcinoma.Julia Thornton Snider, Katharine Batt, Yanyu Wu, Mahlet Gizaw Tebeka, Seth A. Seabury
The American Journal of Managed Care. 2017-10-01
Abstracts/Posters
- Quantifying the Economic Burden of Myelodysplastic Syndromes Among Elderly US PatientsKatharine Batt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in ...Katharine Batt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
We Need More Studies of People with Mild HemophiliaFebruary 25th, 2022- Takeda Drives Continued Scientific Leadership Through Real-World Evidence in Rare Hematological Diseases at ASH 2021December 13th, 2021
ASH 2016 – Saturday, December 3December 3rd, 2015- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
